Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Equity Ratio (2019 - 2025)

Pulmonx has reported Equity Ratio over the past 7 years, most recently at 0.42 for Q4 2025.

  • Quarterly Equity Ratio fell 20.56% to 0.42 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.42 through Dec 2025, down 20.56% year-over-year, with the annual reading at 0.42 for FY2025, 20.56% down from the prior year.
  • Equity Ratio was 0.42 for Q4 2025 at Pulmonx, down from 0.43 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.85 in Q1 2021 and troughed at 0.42 in Q4 2025.
  • The 5-year median for Equity Ratio is 0.69 (2023), against an average of 0.67.
  • Year-over-year, Equity Ratio soared 128.3% in 2021 and then decreased 23.25% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.82 in 2021, then decreased by 3.23% to 0.8 in 2022, then fell by 16.31% to 0.67 in 2023, then fell by 20.82% to 0.53 in 2024, then fell by 20.56% to 0.42 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Equity Ratio are 0.42 (Q4 2025), 0.43 (Q3 2025), and 0.47 (Q2 2025).